Ketamine is classified like a Schedule III managed substance underneath the Controlled Compound Act and, as famous previously mentioned, approved through the FDA for anesthetic indications [seventy three]. Common adverse effects affiliated with anesthetic ketamine use involve emergence reactions, hemodynamic instability, and respiratory depression.